UTHR
HEALTHCAREUnited Therapeutics Corp
AI Insight
What's Moving UTHR Today?
No stock-specific AI insight has been generated for UTHR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$272.12$609.35
$544.33
Fundamentals
Market Cap$22.8B
P/E Ratio19.9
EPS$27.04
Dividend Yield—
Dividend / Share—
ROE20.3%
Profit Margin40.6%
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding42.4M
UTHR News
24 articles- Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics StocksYahoo Finance·Jun 22, 2026
- These 3 Stocks Lowered Their Share Counts Drastically in Q1Marketbeat·Jun 9, 2026
- A Look At United Therapeutics (UTHR) Valuation After Strong Long Term Shareholder ReturnsYahoo Finance·Jun 5, 2026
- Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?Yahoo Finance·Jun 5, 2026
- How The Story Around United Therapeutics (UTHR) Is Shifting On Trials Pricing And ValuationYahoo Finance·Jun 5, 2026
- SDZNY or UTHR: Which Is the Better Value Stock Right Now?Yahoo Finance·Jun 4, 2026
- 1 Cash-Producing Stock with Exciting Potential and 2 We IgnoreYahoo Finance·Jun 3, 2026
- What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One YearMotley Fool·May 30, 2026
- United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech StockInsider Monkey·May 30, 2026
- 2 Mid-Cap Stocks on Our Buy List and 1 We Turn DownYahoo Finance·May 29, 2026
- JPMorgan says large-cap biotech is back as profits and pipelines fuel upsideYahoo Finance·May 28, 2026
- Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments | DelveInsightYahoo Finance·May 25, 2026
- United Therapeutics Explores Pig Heart Transplants And Space Labs As Valuation LagsYahoo Finance·May 22, 2026
- United Therapeutics CEO Martine Rothblatt sells $5.38m UTHR sharesInvesting.com·May 22, 2026
- United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026Yahoo Finance·May 18, 2026
- MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2MYahoo Finance·May 18, 2026
- United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026Yahoo Finance·May 17, 2026
- 5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings CallYahoo Finance·May 16, 2026
- United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical TrialStock Titan·May 15, 2026
- Space-Based Pulmonary Drug Formulation Might Change The Case For Investing In United Therapeutics (UTHR)Yahoo Finance·May 14, 2026
- CPRX or UTHR: Which Is the Better Value Stock Right Now?Yahoo Finance·May 14, 2026
- Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsightGlobeNewswire Inc.·Apr 8, 2026
- Stocks Rise As Powell's Remarks Cool Rate Fears: What's Moving Markets Monday?Benzinga·Mar 30, 2026
- Why Is United Therapeutics Stock Soaring Monday?Benzinga·Mar 30, 2026
All 24 articles loaded
Price Data
Open$542.08
Previous Close$538.30
Day High$546.58
Day Low$539.70
52 Week High$609.35
52 Week Low$272.12
52-Week Range
$272.12$609.35
$544.33
Fundamentals
Market Cap$22.8B
P/E Ratio19.9
EPS$27.04
Dividend Yield—
Dividend / Share—
ROE20.3%
Profit Margin40.6%
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding42.4M
About United Therapeutics Corp
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—